Masaki Shimoji

Sayama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Frequent RBM10 Comutation and a Mutually Exclusive Relationship With Other TP53 Pathway Aberrations in Early-Stage Non-Small-Cell Lung Cancer with EGFR Mutation.

Frequent RBM10 Comutation and a Mutually Exclusive Relationship With Other TP53 Pathway Aberrations in Early-Stage Non-Small-Cell Lung Cancer with EGFR Mutation.

Journal: Clinical lung cancer

Published: December 10, 2025

Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study.

Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study.

Journal: JTO clinical and research reports

Published: August 14, 2024

Clinical factors associated with high PD-L1 expression in patients with early-stage non-small cell lung cancer.

Clinical factors associated with high PD-L1 expression in patients with early-stage non-small cell lung cancer.

Journal: Thoracic cancer

Published: July 08, 2024

A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulation.

A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulation.

Journal: Surgical case reports

Published: September 21, 2023

Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion.

Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: May 21, 2023

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing.

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing.

Journal: JTO clinical and research reports

Published: May 14, 2023

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation.

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation.

Journal: Journal of hematology & oncology

Published: February 21, 2022

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC.

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC.

Journal: JTO clinical and research reports

Published: January 27, 2022

In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial.

In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 01, 2021

Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer.

Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer.

Journal: Clinical lung cancer

Published: August 14, 2021

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments.

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 03, 2021

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study.

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study.

Journal: Translational lung cancer research

Published: November 19, 2020

Showing 1-12 of 39

Last Updated: 09/26/2026